Medical and Pharmaceutical New treatments and detection technologies reshape lung cancer care Lung cancer remains the leading cause of cancer death in the United States Joseph Morton2 days ago
Medical and Pharmaceutical Daraxonrasib shrinks tumours in one-third of lung cancer patients Non-small-cell lung cancer accounts for most lung cancer diagnoses Joseph MortonSeptember 3, 2026
Medical and Pharmaceutical Revolution’s newly approved drug doubles pancreatic cancer survival time A 30-day course of Rasonque costs US$39,800 Rowan DunneAugust 31, 2026
Medical and Pharmaceutical Amplia signs Eli Lilly collaboration for Phase 1b/2b lung cancer trial The companies have already prepared an advanced draft of the trial protocol Joseph MortonAugust 5, 2026
Medical and Pharmaceutical Weight gain between ages 17 and 60 linked to higher cancer risk in major study Researchers compared people in the top 20 per cent of weight gain against those in the bottom 20 per cent Joseph MortonMay 15, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Olympus rolls out advanced SecureFlex EUS biopsy needle in U.S. market The SecureFlex needle supports endoscopic ultrasound-guided fine needle biopsy Joseph MortonJanuary 28, 2026
Medical and Pharmaceutical Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study Pancreatic cancer remains one of the deadliest cancers in the UK Joseph MortonDecember 9, 2025
AI and Autonomy Artificial intelligence boosts accuracy of pancreatic cancer diagnosis Pancreatic ductal adenocarcinoma remains one of the deadliest cancers in the world Joseph MortonDecember 1, 2025
Medical and Pharmaceutical Early detection breakthrough means pancreatic cancer could be diagnosed in minutes The condition ranks as a major cause of cancer mortality worldwide Joseph MortonNovember 3, 2025